| Patient | Marcus Aurelius |
|---|---|
| Date of birth | 1973-04-25 |
| Identifiers | MRN HR-AC004-SYN; SSN (made up) 000-04-1213 |
| Document date | 2026-07-28 |
| Author | Octavia Ashworth-Nnamdi, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Periodic adult preventive visit. [S]
Mr. Aurelius is a 53-year-old man with reflux esophagitis diagnosed ten weeks ago, on omeprazole, chronic insomnia in cognitive behavioral therapy, and long-standing use of an opium-containing herbal paste, who comes for the preventive visit booked at intake. The COVID-19 illness three weeks ago settled in five days without antiviral treatment; the cough has gone and his energy is back. He took no extra remedy while ill and used no cough syrup. He finished the eight-week omeprazole course two weeks ago and has taken it on demand twice since, each time after a late dinner; otherwise he has no reflux symptoms, and he eats his main meal earlier. He has taken the paste on alternate nights since early June; he has decided that from tonight he will take a smaller amount on only two nights a week. He has never had colorectal cancer screening or a pneumococcal or shingles vaccine. [S]
| Element | Detail |
|---|---|
| Visit | Periodic adult preventive visit, age 53 |
| COVID-19 | Resolved after five days; no antiviral |
| Reflux | Eight-week omeprazole course finished two weeks ago; on demand twice since |
| Mood | PHQ-2 1 |
Health risk assessment. Completed by the patient on a tablet in the waiting room and reviewed with him by Dr. Ashworth-Nnamdi. [S]
| Domain | Finding |
|---|---|
| Self-rated health | Good, better than in the spring |
| Psychosocial | Heavy responsibility at work; delegates more after the evening meal; trusted colleagues |
| Substance use | AUDIT-C 2; the herbal paste on alternate nights, about two nights a week from today; no other drugs |
| Tobacco | Never |
| Physical activity | Walks and rides most days, more than 150 minutes a week |
| Nutrition | Two meals a day, the main meal now early in the evening; bread, vegetables, fish and olive oil |
| Sleep | About six hours, improving with CBT-I |
| Safety | Wears a seat belt; no firearms in his quarters; naloxone at the bedside |
| Sexual health | No concerns |
| Activities of daily living | Independent |
| System | Result | Finding |
|---|---|---|
| Constitutional | Negative | No fever; energy back; weight up 1.4 kg since intake |
| Eyes | Negative | No change in vision; uses reading glasses |
| Ears, nose, mouth, and throat | Negative | No hearing loss or sore throat |
| Cardiovascular | Negative | No chest pain, palpitations or ankle swelling |
| Respiratory | Negative | No cough or breathlessness |
| Gastrointestinal | Positive | Heartburn twice in two weeks after late dinners, eased by omeprazole; no pain after meals, difficulty swallowing, or blood in the stool; soft stools on the laxative |
| Genitourinary | Negative | No urinary symptoms |
| Musculoskeletal | Negative | No joint pain |
| Integumentary | Negative | No rash or changing moles |
| Endocrine | Negative | No thirst or frequent urination |
| Psychiatric | Negative | Mood steady; PHQ-2 1 |
11 systems reviewed. [S]
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Opium-containing compounded herbal paste (an electuary of honey, many herbs and poppy, from an overseas supplier; not prescribed and not regulated, so its morphine content is unknown), about a pea-sized amount (roughly 0.5 g) by mouth at bedtime most nights for about six years, and now and then in the morning before a long day | About 0.5 g at bedtime most nights; occasionally a second amount in the morning | Oral route | 2020-05-01 to 2026-06-06 | completed | S |
| Calcium carbonate 500 mg chewable tablet, one or two tablets as needed for heartburn, no more than six a day, until the endoscopy | One or two tablets as needed, at least four hours apart; no more than six a day | Oral route | 2026-05-12 to 2026-05-19 | completed | S |
| Polyethylene glycol 3350 powder, 17 g dissolved in a glass of water by mouth once daily as needed for constipation | 17 g once daily as needed | Oral route | 2026-05-12 | active | S |
| Naloxone 4 mg nasal spray, one spray into one nostril for suspected opioid overdose, repeated in 2 to 3 minutes in the other nostril if there is no response; call 911 | One spray for suspected overdose; repeat every 2 to 3 minutes if needed | Nasal route | 2026-05-12 | active | S |
| Omeprazole 20 mg delayed-release capsule, one capsule by mouth 30 to 60 minutes before breakfast for eight weeks, for erosive esophagitis | One capsule each morning before breakfast for eight weeks | Oral route | 2026-05-19 to 2026-07-14 | completed | S |
| Omeprazole 20 mg delayed-release capsule, one capsule by mouth before breakfast on days after heartburn returns (on-demand therapy after the eight-week course) | One capsule on a day with heartburn; no more than one a day | Oral route | 2026-07-14 | active | S |
| Opium-containing compounded herbal paste (unregulated, strength unknown), about 0.5 g by mouth at bedtime on alternate nights, a reduction he chose and made himself | About 0.5 g at bedtime every other night | Oral route | 2026-06-06 to 2026-07-28 | completed | S |
| Opium-containing compounded herbal paste (unregulated, strength unknown), a smaller amount, about 0.3 g, by mouth at bedtime on about two nights a week, a further reduction he chose | About 0.3 g at bedtime on about two nights a week | Oral route | 2026-07-28 | active | S |
| Acetaminophen 500 mg oral tablet, one or two tablets by mouth every six hours as needed for fever or aches, no more than 3 g a day | One or two tablets every six hours as needed; no more than six a day | Oral route | 2026-07-07 to 2026-07-28 | completed | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 2026-07-28 | Body height | 172 | cm | S |
| 2026-07-28 | Body weight | 64.4 | kg | S |
| 2026-07-28 | Body mass index (BMI) [Ratio] | 21.8 | kg/m2 | S |
| 2026-07-28 | Systolic blood pressure | 118 | mm[Hg] | S |
| 2026-07-28 | Diastolic blood pressure | 76 | mm[Hg] | S |
| 2026-07-28 | Heart rate | 70 | /min | S |
| 2026-07-28 | Respiratory rate | 14 | /min | S |
| 2026-07-28 | Body temperature | 36.6 | Cel | S |
| 2026-07-28 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 2026-07-28 | Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] | 1 | {score} | S | ||
| 2026-07-28 | Total score [AUDIT-C] | 2 | {score} | S |
Vital signs recorded on 2026-07-28; see the Vital Signs section. [S]
| System | Finding |
|---|---|
| Constitutional | Well; weight 64.4 kg, BMI 21.8; blood pressure 118/76, pulse 70 |
| Skin | No suspicious moles |
| Neck | Thyroid normal; no lymph nodes |
| Cardiovascular | Regular rhythm; no murmur |
| Respiratory | Clear |
| Abdomen | Soft and non-tender; no mass |
| Psychiatric | Engaged and calm |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Burning and pressing pain in the upper abdomen and lower chest after meals, for more than a year and worse over three months, with poor appetite, waking at night with pain and a sour taste, and a 3 kg weight loss; not brought on by exertion; normal ECG; cardiac and peptic causes to be excluded | resolved | confirmed | R10.13 | S — Synthetic presenting concern at the index visit, superseded by the diagnosis at endoscopy; its pattern echoes the stomach and chest complaints and the pain with food that Dio describes (D). |
| Gastroesophageal reflux disease with erosive esophagitis, Los Angeles grade B, and a 2 cm sliding hiatal hernia; Helicobacter pylori negative on biopsy; coronary disease excluded by CT coronary angiography; synthetic modern diagnosis for his documented stomach and chest complaints | active | confirmed | K21.00 | S — Synthetic modern diagnosis; the cause of his real complaints is unknown and no historical diagnosis is made. |
| Daily use of an unregulated opium-containing herbal remedy for about six years, for stomach pain and sleep; opioid use disorder criteria not met (one DSM-5-TR criterion, restlessness and poor sleep when he stopped it); expected physiological dependence; constipation and possibly slowed gastric emptying from the opioid | active | confirmed | F11.90 | S — Synthetic modern finding anchored to the theriac he took (D); no opioid use disorder or addiction is attributed to him (the claim is disputed, R). |
| Chronic insomnia disorder for more than a year, with waking from night pain and trouble returning to sleep; Insomnia Severity Index 17 (moderate) | active | confirmed | G47.00 | S — Synthetic modern finding anchored to Galen's account of his sleeplessness without the poppy juice (D, possible). |
| Sustained strain of command: leads a large organization through a long field assignment far from home, with long days and little rest | active | confirmed | Z56.6 | S — Synthetic work strain anchored to his documented years on campaign (D). |
| Constipation from the opioid in his remedy: hard stools every two or three days | active | confirmed | K59.03 | S — Synthetic finding at intake. |
| COVID-19, mild (rapid antigen test positive), without breathlessness or low oxygen; antiviral treatment offered and declined; resolved | resolved | confirmed | U07.1 | S — Synthetic intercurrent illness; not a claim about the Antonine Plague or about any illness in his lifetime. |
Personalized prevention plan. A written copy was given to the patient. [S]
| Service | Status | Detail |
|---|---|---|
| Blood pressure screening | Completed today | 118/76 mmHg |
| Depression screening | Completed today | PHQ-2 score 1 |
| Unhealthy alcohol use screening | Completed today | AUDIT-C score 2 |
| Tobacco use | Completed today | Never smoked |
| Lipid screening and statin assessment | Up to date | Lipids at intake (LDL 133 mg/dL, lipoprotein(a) 38 nmol/L); coronary calcium score 0 and no plaque on CT; low ten-year risk; no statin |
| Diabetes screening | Up to date | A1c 5.4% at intake |
| Colorectal cancer screening | Ordered | Never screened; colonoscopy ordered, with extra bowel preparation because of the opioid |
| Prostate cancer screening | Not indicated | An individual decision from 55; to be discussed then |
| Lung cancer screening | Not indicated | Never smoked |
| HIV screening | Completed today | Once for adults 15 to 65; sent today |
| Hepatitis C screening | Completed today | Once for adults 18 to 79; sent today |
| Hepatitis B screening | Completed today | Once for all adults; sent today before the first vaccine dose |
| Pneumococcal vaccine | Completed today | PCV20, one dose, at 50 or older |
| Zoster vaccine | Completed today | Recombinant zoster vaccine, dose 1 of 2 |
| Hepatitis B vaccine | Completed today | Dose 1 of 2 today, dose 2 at the next visit |
| Tetanus, diphtheria, and pertussis | Up to date | Tdap about six years ago by his report; next in about four years |
| Influenza vaccine | Due | In the autumn |
| COVID-19 vaccine | Due | Due about three months after the infection three weeks ago |
Immunizations given today: Pneumococcal conjugate vaccine, 20-valent (PCV20), single dose for an adult aged 50 or older; Recombinant zoster vaccine (RZV), dose 1 of 2; Hepatitis B vaccine (HepB-CpG), dose 1 of 2 [S]
Guideline basis: Medicare Preventive Services reference: visit templates, screening cascades, and documentation elements (2026); USPSTF A and B Recommendations (2026); Colorectal Cancer: Screening (2021); Adult Immunization Schedule by Age (2026)
Follow-up: Fifteen-week review as planned, with PHQ-9, GAD-7, the Insomnia Severity Index and the second hepatitis B dose. HIV and hepatitis results by phone. Colonoscopy as ordered. Next preventive visit in one year. Next scheduled visit 2026-08-25: fifteen-week review after the eight-week omeprazole course: on-demand therapy, sleep, the remedy, and mood. [S]
Voluntary advance care planning discussion of about 20 minutes, with his consent. He wants full treatment for any condition from which he could recover to his present life and work, and does not want his life prolonged by machines if he could not. He named a health care agent, recorded in the confidential part of the chart and not named here, and will write his wishes down in his own words. To be revisited yearly. [S]